Details of Disease
General Information of Disease (ID: DISNQ872)
| Disease Name | Vitelliform macular dystrophy 2 | |||||
|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        macular Degeneration, polymorphic vitelline; macular dystrophy, vitelliform, 2; Best vitelliform macular dystrophy, multifocal; VMD2; vitelliform macular dystrophy, type 2; BEST1 retinopathy; macular dystrophy, vitelliform, type 2; Best macular dystrophy; vitelliform macular dystrophy, early-onset; vitelliform macular dystrophy, juvenile-onset; vitelliform macular dystrophy type 2; Best Vitelliform Macular Dystrophy; early-onset vitelliform macular dystrophy; polymorphic vitelline macular degeneration; juvenile-onset vitelliform macular dystrophy; Best disease; BVMD; BMD; macular degeneration, polymorphic vitelline
                        
                     
                                     | 
            |||||
| Definition | 
                                         
                        Best vitelliform macular dystrophy (BVMD) is a genetic macular dystrophy characterized by loss of central visual acuity, metamorphopsia and a decrease in the Arden ratio secondary to an egg yolk-like lesion located in the foveal or parafoveal region.
                        
                     
                                     | 
            |||||
| Disease Hierarchy | ||||||
| Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
                     This Disease Is Related to 1 DOT Molecule(s) 
                                                
  | 
            |||||||||||||||||||||||||
